Report Detail

Pharma & Healthcare Global Meningococcal Conjugate Vaccine Market Research Report 2018

  • RnM2139443
  • |
  • 01 June, 2018
  • |
  • Global
  • |
  • 101 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Table of Contents

    Global Meningococcal Conjugate Vaccine Market Research Report 2018

      1 Meningococcal Conjugate Vaccine Market Overview

      • 1.1 Product Overview and Scope of Meningococcal Conjugate Vaccine
      • 1.2 Meningococcal Conjugate Vaccine Segment by Type (Product Category)
        • 1.2.1 Global Meningococcal Conjugate Vaccine Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
        • 1.2.2 Global Meningococcal Conjugate Vaccine Production Market Share by Type (Product Category) in 2017
        • 1.2.3 Menactra
        • 1.2.4 MENVEO
      • 1.3 Global Meningococcal Conjugate Vaccine Segment by Application
        • 1.3.1 Meningococcal Conjugate Vaccine Consumption (Sales) Comparison by Application (2013-2025)
        • 1.3.2 Children
        • 1.3.3 Adults
      • 1.4 Global Meningococcal Conjugate Vaccine Market by Region (2013-2025)
        • 1.4.1 Global Meningococcal Conjugate Vaccine Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
        • 1.4.2 North America Status and Prospect (2013-2025)
        • 1.4.3 Europe Status and Prospect (2013-2025)
        • 1.4.4 Asia-Pacific Status and Prospect (2013-2025)
        • 1.4.5 South America Status and Prospect (2013-2025)
        • 1.4.6 Middle East & Africa Status and Prospect (2013-2025)
      • 1.5 Global Market Size (Value) of Meningococcal Conjugate Vaccine (2013-2025)
        • 1.5.1 Global Meningococcal Conjugate Vaccine Revenue Status and Outlook (2013-2025)
        • 1.5.2 Global Meningococcal Conjugate Vaccine Capacity, Production Status and Outlook (2013-2025)

      2 Global Meningococcal Conjugate Vaccine Market Competition by Manufacturers

      • 2.1 Global Meningococcal Conjugate Vaccine Capacity, Production and Share by Manufacturers (2013-2018)
        • 2.1.1 Global Meningococcal Conjugate Vaccine Capacity and Share by Manufacturers (2013-2018)
        • 2.1.2 Global Meningococcal Conjugate Vaccine Production and Share by Manufacturers (2013-2018)
      • 2.2 Global Meningococcal Conjugate Vaccine Revenue and Share by Manufacturers (2013-2018)
      • 2.3 Global Meningococcal Conjugate Vaccine Average Price by Manufacturers (2013-2018)
      • 2.4 Manufacturers Meningococcal Conjugate Vaccine Manufacturing Base Distribution, Sales Area and Product Type
      • 2.5 Meningococcal Conjugate Vaccine Market Competitive Situation and Trends
        • 2.5.1 Meningococcal Conjugate Vaccine Market Concentration Rate
        • 2.5.2 Meningococcal Conjugate Vaccine Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Meningococcal Conjugate Vaccine Capacity, Production, Revenue (Value) by Region (2013-2018)

      • 3.1 Global Meningococcal Conjugate Vaccine Capacity and Market Share by Region (2013-2018)
      • 3.2 Global Meningococcal Conjugate Vaccine Production and Market Share by Region (2013-2018)
      • 3.3 Global Meningococcal Conjugate Vaccine Revenue (Value) and Market Share by Region (2013-2018)
      • 3.4 Global Meningococcal Conjugate Vaccine Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.5 North America Meningococcal Conjugate Vaccine Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.6 Europe Meningococcal Conjugate Vaccine Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.7 Asia-Pacific Meningococcal Conjugate Vaccine Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.8 South America Meningococcal Conjugate Vaccine Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.9 Middle East & Africa Meningococcal Conjugate Vaccine Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

      4 Global Meningococcal Conjugate Vaccine Supply (Production), Consumption, Export, Import by Region (2013-2018)

      • 4.1 Global Meningococcal Conjugate Vaccine Consumption by Region (2013-2018)
      • 4.2 North America Meningococcal Conjugate Vaccine Production, Consumption, Export, Import (2013-2018)
      • 4.3 Europe Meningococcal Conjugate Vaccine Production, Consumption, Export, Import (2013-2018)
      • 4.4 Asia-Pacific Meningococcal Conjugate Vaccine Production, Consumption, Export, Import (2013-2018)
      • 4.5 South America Meningococcal Conjugate Vaccine Production, Consumption, Export, Import (2013-2018)
      • 4.6 Middle East & Africa Meningococcal Conjugate Vaccine Production, Consumption, Export, Import (2013-2018)

      5 Global Meningococcal Conjugate Vaccine Production, Revenue (Value), Price Trend by Type

      • 5.1 Global Meningococcal Conjugate Vaccine Production and Market Share by Type (2013-2018)
      • 5.2 Global Meningococcal Conjugate Vaccine Revenue and Market Share by Type (2013-2018)
      • 5.3 Global Meningococcal Conjugate Vaccine Price by Type (2013-2018)
      • 5.4 Global Meningococcal Conjugate Vaccine Production Growth by Type (2013-2018)

      6 Global Meningococcal Conjugate Vaccine Market Analysis by Application

      • 6.1 Global Meningococcal Conjugate Vaccine Consumption and Market Share by Application (2013-2018)
      • 6.2 Global Meningococcal Conjugate Vaccine Consumption Growth Rate by Application (2013-2018)
      • 6.3 Market Drivers and Opportunities
        • 6.3.1 Potential Applications
        • 6.3.2 Emerging Markets/Countries

      7 Global Meningococcal Conjugate Vaccine Manufacturers Profiles/Analysis

      • 7.1 GlaxoSmithKline
        • 7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.1.2 Meningococcal Conjugate Vaccine Product Category, Application and Specification
          • 7.1.2.1 Product A
          • 7.1.2.2 Product B
        • 7.1.3 GlaxoSmithKline Meningococcal Conjugate Vaccine Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.1.4 Main Business/Business Overview
      • 7.2 Pfizer
        • 7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.2.2 Meningococcal Conjugate Vaccine Product Category, Application and Specification
          • 7.2.2.1 Product A
          • 7.2.2.2 Product B
        • 7.2.3 Pfizer Meningococcal Conjugate Vaccine Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.2.4 Main Business/Business Overview
      • 7.3 Sanofi
        • 7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.3.2 Meningococcal Conjugate Vaccine Product Category, Application and Specification
          • 7.3.2.1 Product A
          • 7.3.2.2 Product B
        • 7.3.3 Sanofi Meningococcal Conjugate Vaccine Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.3.4 Main Business/Business Overview

      ...

        8 Meningococcal Conjugate Vaccine Manufacturing Cost Analysis

        • 8.1 Meningococcal Conjugate Vaccine Key Raw Materials Analysis
          • 8.1.1 Key Raw Materials
          • 8.1.2 Price Trend of Key Raw Materials
          • 8.1.3 Key Suppliers of Raw Materials
          • 8.1.4 Market Concentration Rate of Raw Materials
        • 8.2 Proportion of Manufacturing Cost Structure
          • 8.2.1 Raw Materials
          • 8.2.2 Labor Cost
          • 8.2.3 Manufacturing Expenses
        • 8.3 Manufacturing Process Analysis of Meningococcal Conjugate Vaccine

        9 Industrial Chain, Sourcing Strategy and Downstream Buyers

        • 9.1 Meningococcal Conjugate Vaccine Industrial Chain Analysis
        • 9.2 Upstream Raw Materials Sourcing
        • 9.3 Raw Materials Sources of Meningococcal Conjugate Vaccine Major Manufacturers in 2017
        • 9.4 Downstream Buyers

        10 Marketing Strategy Analysis, Distributors/Traders

        • 10.1 Marketing Channel
          • 10.1.1 Direct Marketing
          • 10.1.2 Indirect Marketing
          • 10.1.3 Marketing Channel Development Trend
        • 10.2 Market Positioning
          • 10.2.1 Pricing Strategy
          • 10.2.2 Brand Strategy
          • 10.2.3 Target Client
        • 10.3 Distributors/Traders List

        11 Market Effect Factors Analysis

        • 11.1 Technology Progress/Risk
          • 11.1.1 Substitutes Threat
          • 11.1.2 Technology Progress in Related Industry
        • 11.2 Consumer Needs/Customer Preference Change
        • 11.3 Economic/Political Environmental Change

        12 Global Meningococcal Conjugate Vaccine Market Forecast (2018-2025)

        • 12.1 Global Meningococcal Conjugate Vaccine Capacity, Production, Revenue Forecast (2018-2025)
          • 12.1.1 Global Meningococcal Conjugate Vaccine Capacity, Production and Growth Rate Forecast (2018-2025)
          • 12.1.2 Global Meningococcal Conjugate Vaccine Revenue and Growth Rate Forecast (2018-2025)
          • 12.1.3 Global Meningococcal Conjugate Vaccine Price and Trend Forecast (2018-2025)
        • 12.2 Global Meningococcal Conjugate Vaccine Production, Consumption , Import and Export Forecast by Region (2018-2025)
          • 12.2.1 North America Meningococcal Conjugate Vaccine Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
          • 12.2.2 Europe Meningococcal Conjugate Vaccine Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
          • 12.2.3 Asia-Pacific Meningococcal Conjugate Vaccine Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
          • 12.2.4 South America Meningococcal Conjugate Vaccine Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
          • 12.2.5 Middle East & Africa Meningococcal Conjugate Vaccine Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.3 Global Meningococcal Conjugate Vaccine Production, Revenue and Price Forecast by Type (2018-2025)
        • 12.4 Global Meningococcal Conjugate Vaccine Consumption Forecast by Application (2018-2025)

        13 Research Findings and Conclusion

          14 Appendix

          • 14.1 Methodology/Research Approach
            • 14.1.1 Research Programs/Design
            • 14.1.2 Market Size Estimation
            • 14.1.3 Market Breakdown and Data Triangulation
          • 14.2 Data Source
            • 14.2.1 Secondary Sources
            • 14.2.2 Primary Sources

          This report studies the global Meningococcal Conjugate Vaccine market status and forecast, categorizes the global Meningococcal Conjugate Vaccine market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

          In 2017, the global Meningococcal Conjugate Vaccine market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx.x % between 2018 and 2025.

          The major manufacturers covered in this report
          GlaxoSmithKline
          Pfizer
          Sanofi
          ...

          Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
          North America
          Europe
          Asia-Pacific
          South America
          Middle East & Africa

          The regional scope of the study is as follows:
          North America
          United States
          Canada
          Mexico
          Asia-Pacific
          China
          India
          Japan
          South Korea
          Australia
          Indonesia
          Singapore
          Rest of Asia-Pacific
          Europe
          Germany
          France
          UK
          Italy
          Spain
          Russia
          Rest of Europe
          Central & South America
          Brazil
          Argentina
          Rest of South America
          Middle East & Africa
          Saudi Arabia
          Turkey
          Rest of Middle East & Africa

          On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
          Menactra
          MENVEO
          On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
          Children
          Adults

          The study objectives of this report are:
          To analyze and study the global Meningococcal Conjugate Vaccine sales, value, status (2013-2017) and forecast (2018-2025).
          Focuses on the key Meningococcal Conjugate Vaccine manufacturers, to study the sales, value, market share and development plans in future.
          Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
          To define, describe and forecast the market by type, application and region.
          To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
          To identify significant trends and factors driving or inhibiting the market growth.
          To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
          To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
          To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
          To strategically profile the key players and comprehensively analyze their growth strategies.

          In this study, the years considered to estimate the market size of Meningococcal Conjugate Vaccine are as follows:
          History Year: 2013-2017
          Base Year: 2017
          Estimated Year: 2018
          Forecast Year 2018 to 2025

          For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

          Key Stakeholders
          Meningococcal Conjugate Vaccine Manufacturers
          Meningococcal Conjugate Vaccine Distributors/Traders/Wholesalers
          Meningococcal Conjugate Vaccine Subcomponent Manufacturers
          Industry Association
          Downstream Vendors

          Available Customizations
          With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
          Regional and country-level analysis of the Meningococcal Conjugate Vaccine market, by end-use.
          Detailed analysis and profiles of additional market players.


          Summary:
          Get latest Market Research Reports on Meningococcal Conjugate Vaccine . Industry analysis & Market Report on Meningococcal Conjugate Vaccine is a syndicated market report, published as Global Meningococcal Conjugate Vaccine Market Research Report 2018. It is complete Research Study and Industry Analysis of Meningococcal Conjugate Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

          Last updated on

          REPORT YOU MIGHT BE INTERESTED

          Purchase this Report

          $2,900.00
          $5,800.00
          2,119.06
          4,238.12
          2,382.09
          4,764.18
          300,857.60
          601,715.20
          211,773.08
          423,546.16
          Credit card Logo

          Related Reports


          Reason to Buy

          Request for Sample of this report